rs1557006239
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PM1PM2PP3_StrongPP5_Very_Strong
The NM_000377.3(WAS):c.91G>A(p.Glu31Lys) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000377.3 missense
Scores
Clinical Significance
Conservation
Publications
- Wiskott-Aldrich syndromeInheritance: XL, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet
- X-linked severe congenital neutropeniaInheritance: XL Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
- thrombocytopenia 1Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| WAS | NM_000377.3 | c.91G>A | p.Glu31Lys | missense_variant | Exon 1 of 12 | ENST00000376701.5 | NP_000368.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 22
ClinVar
Submissions by phenotype
Wiskott-Aldrich syndrome;C1839163:Thrombocytopenia 1;C1845987:X-linked severe congenital neutropenia Pathogenic:1
This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 31 of the WAS protein (p.Glu31Lys). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with Wiskott-Aldrich syndrome (PMID: 8528198, 8682510, 11442475, 15284122, 21185603, 22523910, 25476427, 25792466, 28623282). In at least one individual the variant was observed to be de novo. This variant is also known as c.125G>A. ClinVar contains an entry for this variant (Variation ID: 528222). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt WAS protein function. Experimental studies have shown that this missense change affects WAS function (PMID: 19817875). For these reasons, this variant has been classified as Pathogenic. -
not provided Pathogenic:1
The E31K variant has been published previously in association with Wiskott-Aldrich syndrome (Kolluri et al., 1995; Ariga et al., 1997). The variant is not observed in large population cohorts (Lek et al., 2016). E31K is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. In-silico analyses, including protein predictors and evolutionary conservation, support a deleterious effect. Additionally, functional studies have shown E31K damages the ability of the WAS protein to bind WIP (Rajmohan et al., 2009). In summary, this variant is likely pathogenic. -
Wiskott-Aldrich syndrome Pathogenic:1
This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 31 of the WAS protein (p.Glu31Lys). Experimental studies have shown that this missense change affects WAS function (PMID: 19817875). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt WAS protein function. ClinVar contains an entry for this variant (Variation ID: 528222). This variant is also known as c.125G>A. This missense change has been observed in individual(s) with Wiskott-Aldrich syndrome (PMID: 8528198, 8682510, 11442475, 15284122, 21185603, 22523910, 25476427, 25792466, 28623282). In at least one individual the variant was observed to be de novo. This variant is not present in population databases (gnomAD no frequency). For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at